10X GENOMICS INC's ticker is TXG and the CUSIP is 88025U109. A total of 2 filers reported holding 10X GENOMICS INC in Q4 2023. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $43,279,913 | -64.4% | 1,049,210 | -51.7% | 0.62% | -55.2% |
| Q2 2023 | $121,402,470 | -27.6% | 2,174,113 | -27.7% | 1.39% | -42.0% |
| Q1 2023 | $167,672,772 | +53.1% | 3,005,427 | 0.0% | 2.40% | +21.5% |
| Q4 2022 | $109,517,760 | +27.9% | 3,005,427 | 0.0% | 1.98% | +17.7% |
| Q3 2022 | $85,595,000 | -31.4% | 3,005,427 | +9.0% | 1.68% | -31.2% |
| Q2 2022 | $124,811,000 | +681.8% | 2,758,245 | +1214.3% | 2.45% | +1289.8% |
| Q1 2022 | $15,964,000 | -48.9% | 209,865 | 0.0% | 0.18% | -52.4% |
| Q4 2021 | $31,261,000 | +430.8% | 209,865 | +418.8% | 0.37% | +345.8% |
| Q3 2021 | $5,889,000 | – | 40,451 | – | 0.08% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Foresite Capital Management II, LLC | 1,753,528 | $133,391,000 | 100.00% |
| Foresite Capital Management I, LLC | 750,000 | $57,053,000 | 99.71% |
| 12 West Capital Management LP | 2,518,500 | $191,582,000 | 11.65% |
| Meritech Capital Associates V L.L.C. | 1,336,253 | $101,649,000 | 9.59% |
| Blue Water Life Science Advisors, LP | 211,917 | $16,121,000 | 7.65% |
| Decheng Capital Management III (Cayman), LLC | 303,984 | $23,124,000 | 7.09% |
| FINANCIAL CONSULATE, INC | 154,942 | $11,786,000 | 4.53% |
| Evolutionary Tree Capital Management, LLC | 54,128 | $4,118,000 | 2.86% |
| HARVARD MANAGEMENT CO INC | 186,143 | $14,160,000 | 1.43% |
| Brown Capital Management | 1,663,469 | $126,540,000 | 1.26% |